TS Financial Group (TSFG)’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Hold
2,569
﹤0.01% 490
2026
Q1
$23K Hold
2,569
﹤0.01% 451
2025
Q4
$47K Hold
2,569
0.01% 347
2025
Q3
$38K Hold
2,569
0.01% 378
2025
Q2
$47K Hold
2,569
0.01% 337
2025
Q1
$51K Buy
+2,569
New +$44.4K 0.01% 311

Other funds holding ADMA

TS Financial Group (TSFG)'s ADMA Position: Q2 2026 in Review

TS Financial Group (TSFG) held its ADMA Biologics (ADMA) position steady in Q2 2026 at 2,569 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

TS Financial Group (TSFG) first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $51K in Q1 2025. 79 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • TS Financial Group (TSFG) held 2,569 shares of ADMA Biologics worth $22K as of Q2 2026.
  • TS Financial Group (TSFG) left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #490 holding.
  • TS Financial Group (TSFG) first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • TS Financial Group (TSFG)'s ADMA Biologics position peaked at $51K in Q1 2025.
  • 79 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.